Active Biotech AB(GB:0GQU)
kr 3.200.00 (0.00%)
GB:0GQU
Active Biotech AB financials statements
kr 3.20
At close:0.00 (0.00%)
Active Biotech AB (0GQU) Ratios
0 Followers
Active Biotech AB Ratios
GB:0GQU's free cash flow for Q3 2026 was kr-7.20M. For the 2026 fiscal year, GB:0GQU's free cash flow was increased by kr0.00 and operating cash flow was kr-7.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.66 | 4.40 | 3.73 | 3.66 | 5.64 |
| Quick Ratio | 4.66 | 4.40 | 3.73 | 3.66 | 5.64 |
| Cash Ratio | 4.49 | 3.08 | 3.49 | 3.47 | 5.36 |
| Solvency Ratio | -2.45 | -3.40 | -3.30 | -3.47 | -4.80 |
| Operating Cash Flow Ratio | -2.23 | -4.54 | -4.41 | -4.55 | -4.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -24.47 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 53.00M | kr 28.07M | kr 25.33M | kr 27.63M | kr 45.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.07 | 0.10 | 0.12 | 0.02 |
| Debt-to-Equity Ratio | 0.03 | 0.10 | 0.15 | 0.17 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.09 | 0.13 | 0.15 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.35 | 1.44 | 1.48 | 1.22 |
| Debt Service Coverage Ratio | 0.00 | -20.95 | 0.00 | -276.66 | -1868.35 |
| Interest Coverage Ratio | 0.00 | -224.86 | 0.00 | -281.00 | -1914.69 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.02 | 0.02 | 0.00 |
| Net Debt to EBITDA | 1.76 | 0.63 | 0.72 | 0.63 | 1.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.55% | 100.12% |
| EBT Per EBIT | 99.20% | 98.99% | 98.53% | 100.84% | 100.09% |
| Return on Assets (ROA) | -53.13% | -91.20% | -103.98% | -115.07% | -87.82% |
| Return on Equity (ROE) | -67.09% | -122.86% | -149.35% | -170.06% | -106.88% |
| Return on Capital Employed (ROCE) | -67.50% | -116.03% | -138.07% | -148.64% | -106.14% |
| Return on Invested Capital (ROIC) | -65.61% | -105.85% | -132.01% | -142.76% | -104.45% |
| Return on Tangible Assets | -53.32% | -91.72% | -104.56% | -115.62% | -87.82% |
| Earnings Yield | -0.60% | -0.86% | -81.84% | -57.83% | -41.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.33 | 1.13 | 0.53 | 0.42 | 0.46 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1121.23 | -323.16 | -691.43 | -861.93 | -787.32 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1121.23 | 323.16 | 691.43 | 861.93 | 787.32 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.10 | -0.17 | -0.21 | -0.19 |
| Free Cash Flow Per Share | -0.02 | -0.10 | -0.17 | -0.21 | -0.19 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | -223.88 | 0.00 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | -223.88 | 0.00 |
| Operating Cash Flow Coverage Ratio | -18.67 | -12.69 | -10.06 | -9.08 | -46.82 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.52% | -0.88% | -81.74% | -54.28% | -38.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -166.06 | -116.12 | -1.22 | -1.73 | -2.42 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 111.47 | 142.63 | 1.82 | 2.94 | 2.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -191.29 | -113.23 | -1.22 | -1.84 | -2.62 |
| Price-to-Operating Cash Flow Ratio | -191.29 | -113.23 | -1.22 | -1.85 | -2.62 |
| Price-to-Earnings Growth (PEG) Ratio | 2.36 | 2.59 | 0.05 | -0.12 | -0.46 |
| Enterprise Value Multiple | -170.40 | -118.80 | -0.55 | -1.16 | -1.42 |
| Enterprise Value | 6.13B | 4.55B | 24.29M | 65.73M | 68.79M |
| EV to EBITDA | -170.40 | -118.80 | -0.55 | -1.16 | -1.42 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -189.34 | -112.63 | -0.53 | -1.19 | -1.49 |
| EV to Operating Cash Flow | -189.33 | -112.63 | -0.53 | -1.20 | -1.49 |
| Tangible Book Value Per Share | 0.04 | 0.08 | 0.11 | 0.13 | 0.19 |
| Shareholders’ Equity Per Share | 0.04 | 0.08 | 0.11 | 0.13 | 0.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.01 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.09 | -0.17 | -0.23 | -0.20 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.00 |
| Interest Burden | 0.99 | 0.99 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.87 | 1.03 | 1.00 | 0.94 | 0.93 |
Currency in SEK
